Zhengqing Fengtongning makes its debut at the Macao Medical Association Joint General Assembly Academic Conference.
Category:
Release time:
2026-09-21
On September 18, the Medical Professionals’ Academic Conference, hosted by the Federation of Medical Associations of Macao, was held at the Fisherman’s Wharf Convention and Exhibition Centre in Macao. Professor Huang Wei, a trainer in the Zhengqing Fengtongning triple‑sequential therapy and Director of the Rehabilitation Medicine Center at the Second Affiliated Hospital of Guangdong Medical University, attended and delivered a keynote address titled “Advances in the Clinical Application of Sinomenine and Considerations on Its Safety.” The event was also attended by Guan Bingquan, Chairman of the Federation of Medical Associations of Macao, along with numerous local medical professionals. This conference serves as an important platform for professional exchange within Macao’s medical community, has been incorporated into the city’s continuing professional development credit system for healthcare personnel, enjoys widespread recognition among local medical and nursing staff, and drew over 800 participants—both online and offline.
During the lecture, Professor Huang Wei drew on his team’s extensive clinical experience to provide an in-depth analysis of the clinical applications of Zhengqing Fengtongning in areas such as neurological rehabilitation, orthopedic rehabilitation, and the prevention and management of gout. By presenting multiple sets of pre‑ and post‑treatment comparative cases, he vividly demonstrated the drug’s clinical utility, while also systematically reviewing and sharing insights into its safety profile, thereby offering valuable clinical guidance for healthcare professionals in Macao.
The Zhengqing Fengtongning product line is a core offering of the Zhengqing Group, widely used for rheumatic and pain‑related conditions. Zhengqing Fengtongning sustained‑release tablets have been launched in Macao, providing local patients with a convenient oral formulation option.
This academic conference, held under the auspices of the Macao Medical Professionals United Association, aimed to highlight the clinical value of the Zhengqing Fengtongning product among Macao’s medical community, thereby further enhancing the brand’s visibility within both the medical profession and broader society in Macao. Looking ahead, Zhengqing Group will continue to establish robust platforms for academic exchange across the Guangdong–Hong Kong–Macao Greater Bay Area, consistently disseminating clinical research findings in traditional Chinese medicine. By collaborating with leading experts and industry organizations, the company will host more high‑quality academic events, supporting the internationalization and localized implementation of TCM and ensuring that premium TCM products benefit an even wider audience in Hong Kong and Macao.